Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Claeysen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Annals of the New York Academy of Sciences|February 3, 1999
5-HT4 receptors: gene, transduction and effects on olfactory memoryJ Bockaert, S Claeysen, M Sebben, et al.
Current Drug Targets. CNS and Neurological Disorders|February 18, 2004
5-HT4 receptorsJ Bockaert, S Claeysen, V Compan, et al.
Molecular Pharmacology|April 30, 1999
Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domainS Claeysen, M Sebben, C Becamel, et al.
FEBS Letters|November 25, 1996
Cloning, expression and pharmacology of the mouse 5-HT(4L) receptorS Claeysen, M Sebben, L Journot, et al.
Neuroreport|November 14, 1997
Cloning and expression of human 5-HT4S receptors. Effect of receptor density on their coupling to adenylyl cyclaseS Claeysen, P Faye, M Sebben, et al.
Annals of the New York Academy of Sciences|February 3, 1999
5-HT4 receptors: cloning and expression of new splice variantsS Claeysen, P Faye, M Sebben, et al.
EMBO Reports|March 17, 2001
Constitutively active mutants of 5-HT4 receptors are they in unique active states?S Claeysen, M Sebben, C Bécamel, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 10, 2000
Inhibition of glucose-induced insulin secretion by a peripheral-type benzodiazepine receptor ligand (PK11195)D Pujalte, S Claeysen, S Dietz, et al.
Cytogenetics and Cell Genetics|January 1, 1997
Assignment of 5-hydroxytryptamine receptor (HTR4) to human chromosome 5 bands q31-->q33 by in situ hybridizationS Claeysen, P Faye, M Sebben, et al.
Molecular Pharmacology|June 22, 2000
Pharmacological properties of 5-Hydroxytryptamine(4) receptor antagonists on constitutively active wild-type and mutated receptorsS Claeysen, M Sebben, C Bécamel, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Annals of the New York Academy of Sciences|February 3, 1999
5-HT4 receptors: gene, transduction and effects on olfactory memoryJ Bockaert, S Claeysen, M Sebben, et al.
Current Drug Targets. CNS and Neurological Disorders|February 18, 2004
5-HT4 receptorsJ Bockaert, S Claeysen, V Compan, et al.
Molecular Pharmacology|April 30, 1999
Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domainS Claeysen, M Sebben, C Becamel, et al.
FEBS Letters|November 25, 1996
Cloning, expression and pharmacology of the mouse 5-HT(4L) receptorS Claeysen, M Sebben, L Journot, et al.
Neuroreport|November 14, 1997
Cloning and expression of human 5-HT4S receptors. Effect of receptor density on their coupling to adenylyl cyclaseS Claeysen, P Faye, M Sebben, et al.
Annals of the New York Academy of Sciences|February 3, 1999
5-HT4 receptors: cloning and expression of new splice variantsS Claeysen, P Faye, M Sebben, et al.
EMBO Reports|March 17, 2001
Constitutively active mutants of 5-HT4 receptors are they in unique active states?S Claeysen, M Sebben, C Bécamel, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 10, 2000
Inhibition of glucose-induced insulin secretion by a peripheral-type benzodiazepine receptor ligand (PK11195)D Pujalte, S Claeysen, S Dietz, et al.
Cytogenetics and Cell Genetics|January 1, 1997
Assignment of 5-hydroxytryptamine receptor (HTR4) to human chromosome 5 bands q31-->q33 by in situ hybridizationS Claeysen, P Faye, M Sebben, et al.
Molecular Pharmacology|June 22, 2000
Pharmacological properties of 5-Hydroxytryptamine(4) receptor antagonists on constitutively active wild-type and mutated receptorsS Claeysen, M Sebben, C Bécamel, et al.
Pageof 2